A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects

NCT02637037 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence
Fixed Dose Combination Tablets
Healthy Male and Female Subjects

Interventions

DRUG: dapagliflozin/metformin XR 5/500 mg test drug (Mount Vernon)
DRUG: dapagliflozin/metformin XR 5/500 mg reference drug (Humacao)
DRUG: dapagliflozin/metformin XR 10/1000 mg test drug (Mount Vernon)
DRUG: dapagliflozin/metformin XR 10/1000 mg reference drug (Humacao)

Sponsor

AstraZeneca